If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: -0.0025 (-2.13%)
Spread: 0.01 (9.091%)
Open: 0.1175
High: 0.1175
Low: 0.11
Prev. Close: 0.1175
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convertible Loan Agreement

22 Feb 2023 07:00

RNS Number : 6213Q
Synergia Energy Ltd
22 February 2023
 

RNS Announcement

 

22 February 2023

AIM: SYN

Convertible Loan Agreement

 

Synergia Energy Ltd (AIM: SYN) (the "Company") is pleased to advise that it has entered into a convertible loan agreement with certain sophisticated and/or professional existing and new shareholders to secure a new convertible loan facility of £650,000 (the "Convertible Loan").

 

Summary of Key Terms of the Convertible Loan

 

Maturity Date:

13 February 2024

 

Option Date:

13 November 2023

 

Interest Rate: 

5%

 

Conversion Terms:

Option to convert the loan and interest payable (to that point) in the period between the Option Date and the Maturity Date. If conversion elected, loan principal and accrued interest is payable by the Company in new fully paid ordinary shares ("Common Shares") at a £0.0008 conversion price, equating to a maximum issue of, in aggregate, 853,125,000 new Common Shares. No option for the Company to elect to repay ahead of Maturity Date, or for the Company to elect repayment to be made in cash.

 

Security: 

Unsecured

 

Arrangement fee:

None

 

 

Standard form representations and warranties have been agreed between the Company and the Convertible Loan lenders. The Convertible Loan proceeds are expected to be received by 28 February 2023 and will be applied to general working capital purposes.

 

Related Party Transaction

 

Republic Investment Management Pte Ltd ("Republic") participated in £326,000 of the Convertible Loan and accordingly will be issued a maximum of 407,500,000 new Common Shares at Maturity (in the event that it elects to convert the principal and accrued interest at that time). Republic has a current shareholding in the Company of 16.8% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies ("AIM Rules"). Accordingly, entering into the Convertible Loan with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the Convertible Loan with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

Additionally, Republic has confirmed that it is a 'sophisticated investor', 'professional investor' or otherwise exempt investor for the purposes of section 708 of the Corporations Act 2001 (Cth) ("Corporations Act") and that it's 'voting power' (along with its 'associates') will not increase from 16.8% to above 20%, for the purposes of Part 6.1 of the Corporations Act.

 

 

For further information, please contact:

 

Investor Enquires

Synergia Energy Ltd

Briana Stayt

Investor Relations

Email: bstayt@synergiaenergy.com

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Ritchie Balmer/ Rory Murphy

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Investor Relations

Patrick d'Ancona / Finlay Thomson

Email: patrick.dancona@vigoconsulting.com

finlay.thomson@vigoconsulting.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDFLFLXLLXBBX
Date   Source Headline
25th Apr 20197:00 amRNSTrading Update and Restatement of Accounts
19th Feb 20197:00 amRNSTrading Statement
20th Dec 20184:37 pmRNSDirector/PDMR Shareholding
20th Dec 201811:35 amRNSResult of General Meeting and Change of Name
20th Dec 20187:00 amRNSDirector/PDMR Shareholding
14th Dec 20182:23 pmRNSDirector/PDMR Shareholding
14th Dec 201810:35 amRNSDirector/PDMR Shareholding
5th Dec 20186:27 pmRNSDirector/PDMR Shareholding
5th Dec 201810:16 amRNSHolding(s) in Company
5th Dec 201810:12 amRNSHolding(s) in Company
3rd Dec 20187:00 amRNSHalf-year Report
16th Nov 201811:01 amRNSNotice of Results
5th Oct 20188:00 amRNSTrading Statement
28th Aug 20188:36 amRNSHolding(s) in Company
30th Jul 20182:36 pmRNSResult of AGM
25th Jul 20181:54 pmRNSDirector/PDMR Shareholding
16th Jul 20188:13 amRNSDirector/PDMR Shareholding
9th Jul 20181:46 pmRNSAnnual Financial Report
2nd Jul 20187:00 amRNSFinal Results
22nd Jun 20187:00 amRNSNotice of Results
2nd May 20187:00 amRNSTrading Update
11th Apr 201811:02 amRNSUK Investor Show
16th Mar 20182:22 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTrading Statement
6th Dec 20177:00 amRNSHalf-year Report
20th Nov 20179:38 amRNSNotice of Results
17th Nov 201710:54 amRNSHolding(s) in Company
5th Oct 20173:48 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:43 pmRNSDirector/PDMR Dealing and Issue of Equity
2nd Oct 20177:00 amRNSTrading Update
1st Aug 20173:42 pmRNSResult of AGM
12th Jul 201711:32 amRNSHolding(s) in Company
11th Jul 20179:19 amRNSHolding(s) in Company
7th Jul 20174:41 pmRNSAnnual Financial Report
3rd Jul 20177:00 amRNSFinal Results
12th Jun 20177:00 amRNSNotice of Results
8th Jun 20175:06 pmRNSHolding(s) in Company
5th Jun 20179:32 amRNSHolding(s) in Company
1st Jun 20174:28 pmRNSApplication for Admission
26th May 20177:00 amRNSPlacing to raise £3.74 million
2nd May 20177:00 amRNSTrading Update
23rd Mar 20178:37 amRNSHolding(s) in Company
27th Feb 20177:00 amRNSPresentation at ShareSoc Growth Company Seminar
20th Feb 20171:30 pmRNSDirector/PDMR Shareholding
13th Feb 20177:00 amRNSTrading Update
30th Jan 20173:45 pmRNSIssue of Equity and Directors' Shareholdings
20th Jan 201711:43 amRNSResult of Scrip Dividend Alternative
12th Jan 20177:00 amRNSGrowth & Innovation Forum
11th Jan 20172:38 pmRNSDirector/PDMR Shareholding
29th Dec 201610:15 amRNSScrip Dividend Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.